Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 55951 - 55975 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	CA4	762	downregulated	panobinostat results in decreased expression of CA4 mRNA	17q23.1	A21037
Panobinostat	Approved Investigational	CA8	767	upregulated	panobinostat results in increased expression of CA8 mRNA	8q12.1	A21037
Panobinostat	Approved Investigational	CACNA2D1	781	upregulated	panobinostat results in increased expression of CACNA2D1 mRNA	7q21.11	A21037
Panobinostat	Approved Investigational	CACNB2	783	downregulated	panobinostat results in decreased expression of CACNB2 mRNA	10p12	A21037
Panobinostat	Approved Investigational	CADM4	199731	downregulated	panobinostat results in decreased expression of CADM4 mRNA	19q13.31	A21037
Panobinostat	Approved Investigational	CALB2	794	upregulated	panobinostat results in increased expression of CALB2 mRNA	16q22.2	A21037
Panobinostat	Approved Investigational	CALCA	796	upregulated	panobinostat results in increased expression of CALCA mRNA	11p15.2	A21037
Panobinostat	Approved Investigational	CAPN6	827	downregulated	panobinostat results in decreased expression of CAPN6 mRNA	Xq23	A21037
Panobinostat	Approved Investigational	CASP8	841	upregulated	panobinostat results in increased expression of CASP8 mRNA	2q33.1	A21037
Panobinostat	Approved Investigational	CBLC	23624	upregulated	panobinostat results in increased expression of CBLC mRNA	19q13.32	A21037
Panobinostat	Approved Investigational	CCDC136	64753	downregulated	panobinostat results in decreased expression of CCDC136 mRNA	7q32.1	A21037
Panobinostat	Approved Investigational	CCDC140	151278	upregulated	panobinostat results in increased expression of CCDC140 mRNA	2q36.1	A21037
Panobinostat	Approved Investigational	CCDC177	56936	downregulated	panobinostat results in decreased expression of CCDC177 mRNA	14q24.1	A21037
Panobinostat	Approved Investigational	CCDC69	26112	upregulated	panobinostat results in increased expression of CCDC69 mRNA	5q33.1	A21037
Panobinostat	Approved Investigational	CCKBR	887	downregulated	panobinostat results in decreased expression of CCKBR mRNA	11p15.4	A21037
Panobinostat	Approved Investigational	CCL26	10344	upregulated	panobinostat results in increased expression of CCL26 mRNA	7q11.23	A21037
Panobinostat	Approved Investigational	CCNG2	901	downregulated	panobinostat results in decreased expression of CCNG2 mRNA	4q21.1	A21037
Panobinostat	Approved Investigational	CCNT2	905	downregulated	panobinostat results in decreased expression of CCNT2 mRNA	2q21.3	A21037
Panobinostat	Approved Investigational	CD24	100133941	upregulated	panobinostat results in increased expression of CD24 mRNA	6q21	A21037
Panobinostat	Approved Investigational	CD44	960	upregulated	panobinostat results in increased expression of CD44 mRNA	11p13	A21037
Panobinostat	Approved Investigational	CD52	1043	upregulated	panobinostat results in increased expression of CD52 mRNA	1p36.11	A21037
Panobinostat	Approved Investigational	CD55	1604	upregulated	panobinostat results in increased expression of CD55 mRNA	1q32.2	A21037
Panobinostat	Approved Investigational	CD74	972	upregulated	panobinostat results in increased expression of CD74 mRNA	5q33.1	A21037
Panobinostat	Approved Investigational	CD9	928	upregulated	panobinostat results in increased expression of CD9 mRNA	12p13.31	A21037
Panobinostat	Approved Investigational	CDC42EP3	10602	downregulated	panobinostat results in decreased expression of CDC42EP3 mRNA	2p22.2	A21037

Displaying entries 55951 - 55975 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability